1. Home
  2. NOTV vs BDSX Comparison

NOTV vs BDSX Comparison

Compare NOTV & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • BDSX
  • Stock Information
  • Founded
  • NOTV 1974
  • BDSX 2005
  • Country
  • NOTV United States
  • BDSX United States
  • Employees
  • NOTV N/A
  • BDSX N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • BDSX Precision Instruments
  • Sector
  • NOTV Health Care
  • BDSX Health Care
  • Exchange
  • NOTV Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • NOTV 137.5M
  • BDSX 115.4M
  • IPO Year
  • NOTV 1997
  • BDSX 2020
  • Fundamental
  • Price
  • NOTV $2.71
  • BDSX $0.31
  • Analyst Decision
  • NOTV Strong Buy
  • BDSX Strong Buy
  • Analyst Count
  • NOTV 1
  • BDSX 5
  • Target Price
  • NOTV $5.00
  • BDSX $1.75
  • AVG Volume (30 Days)
  • NOTV 595.3K
  • BDSX 25.4M
  • Earning Date
  • NOTV 05-07-2025
  • BDSX 05-13-2025
  • Dividend Yield
  • NOTV N/A
  • BDSX N/A
  • EPS Growth
  • NOTV N/A
  • BDSX N/A
  • EPS
  • NOTV N/A
  • BDSX N/A
  • Revenue
  • NOTV $480,402,000.00
  • BDSX $74,463,000.00
  • Revenue This Year
  • NOTV $5.57
  • BDSX $19.92
  • Revenue Next Year
  • NOTV $5.23
  • BDSX $29.03
  • P/E Ratio
  • NOTV N/A
  • BDSX N/A
  • Revenue Growth
  • NOTV N/A
  • BDSX 35.76
  • 52 Week Low
  • NOTV $1.15
  • BDSX $0.17
  • 52 Week High
  • NOTV $6.48
  • BDSX $2.04
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 60.76
  • BDSX 39.52
  • Support Level
  • NOTV $1.96
  • BDSX $0.29
  • Resistance Level
  • NOTV $2.96
  • BDSX $0.37
  • Average True Range (ATR)
  • NOTV 0.24
  • BDSX 0.07
  • MACD
  • NOTV 0.08
  • BDSX 0.01
  • Stochastic Oscillator
  • NOTV 75.00
  • BDSX 40.17

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: